Patent details

92940 Product Name: Pembrolizumab

Basic Information

Publication number:
92940
Type:
SPC
SPC Type:
Medizin-
Basic Patent Number:
EP037411543
Legal Status:
Aktiv
Application number:
92940
First applicant's nationality:
Procedural language:
Französisch

Paediatric Extension

SPC Extension Filing Date:
30/06/2023
SPC Extension Agent Name:
Dennemeyer & Associates S.A.
SPC Extension Status:
Erteilt
SPC Extension Grant Date:
21/10/2024
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1024 - Pembrolizumab
Marketing Authorization Type:
Marketing Authorization Date:
21/07/2015
Marketing Authorization Status:
akzeptiert
Marketing Authorization Country:

Dates

Filing date:
06/01/2016
First Marketing Authorization date:
21/07/2015
Grant date:
07/03/2016
Activation date:
02/07/2023
Publication date:
07/03/2016
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
02/07/2028
SPC Extension Expiration:
02/01/2029
Rejection date:
Withdrawal date:

Owner

From:
06/01/2016
 
 

Name:
Honjo Tasuku
Address:
19-4, Osagi-cho, Iwakura, Sakyo-ku, Kyoto-shi, Kyoto 606-0001, Japan (JP)

Name:
ONO PHARMACEUTICAL CO. LTD.
Address:
1-5, Doshomachi 2-chome Chuo-ku, Osaka-shi, Osaka 541-8526, Japan (JP)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
06/01/2016
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxemburg (LU)
To:

Inventor

1

Name:
HONJO Tasuku
Address:
Japan (JP)

2

Name:
MINATO Nagahiro
Address:
Japan (JP)

3

Name:
IWAI Yoshiko, c/o The Rockefeller University
Address:
Vereinigte Staaten (US)

4

Name:
SHIBAYAMA Shiro, c/o Ono Pharmaceutical Co., Ltd.
Address:
Japan (JP)

Publication

Bulletin

1

Bulletin Heading:
SPCX1
Bulletin edition number:
2023/08
Publication date:
03/07/2023
Description:
Sektion G : Ergänzende Schutzzertifikate – Anträge auf Verlängerungen – I1E Veröffentlichung

2

Bulletin Heading:
SPCX2
Bulletin edition number:
2024/13
Publication date:
05/11/2024
Description:
Sektion H : Erteilte Verlängerungen für ergänzende Schutzzertifikate – I2E Veröffentlichung

3

Bulletin Heading:
SPC3
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Sektion E : Veröffentlichung In Kraft getretene ergänzende Schutzzertifikate – IA Veröffenlichung

Annual Fees

Annual Fee Due Date:
31/07/2025
Annual Fee Number:
23
Annual Fee Amount:
430 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/06/2024
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
420 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
30/06/2023 Antragsformular 4
30/06/2023 Genehmigung für das Inverkehrbringen 3
30/06/2023 Zusammenfassung der Merkmale des Erzeugnisses 137
30/06/2023 Pädiatrisches Prüfkonzept 1
30/06/2023 Ausgehende Korrespondenz 1
30/06/2023 Veröffentlichung 1
21/10/2024 Veröffentlichung 1
21/10/2024 Zertifikat 1
30/06/2023 FNET_DC_FRONTPAGE 1
22/10/2024 Ausgehende Korrespondenz 1